Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 in Patients With Friedreich's Ataxia
NCT02445794Phase 2Completed
- Sponsor
- BioJiva LLC
- Start
- Aug 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RT001 in Friedreich's ataxia (FA), sponsored by BioJiva LLC. Started Aug 2015; status: completed.
02
Drugs
RT001
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT02445794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445794.